Form 8-K - Current report:
SEC Accession No. 0000950170-24-100200
Filing Date
2024-08-23
Accepted
2024-08-23 16:23:22
Documents
11
Period of Report
2024-08-22
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tlis-20240822.htm   iXBRL 8-K 45089
  Complete submission text file 0000950170-24-100200.txt   189962

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tlis-20240822.xsd EX-101.SCH 47767
13 EXTRACTED XBRL INSTANCE DOCUMENT tlis-20240822_htm.xml XML 4895
Mailing Address 1375 WEST FULTON MARKET SUITE 700 CHICAGO IL 60607
Business Address 1375 WEST FULTON MARKET SUITE 700 CHICAGO IL 60607 650-433-3000
Talis Biomedical Corp (Filer) CIK: 0001584751 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40047 | Film No.: 241236604
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)